NDC80 and neoplasm: KNTC2 siRNA‐LNP significantly inhibited the in vivo growth of Hep3B. KNTC2 siRNAs‐LNP led to tumor shrinkage and protected normal hepatocytes, decreasing plasma AST and ALT levels.